| Identification | Back Directory | [Name]
PF-00299804 | [CAS]
1042385-75-0 | [Synonyms]
PF-804
PF-00299804-3
Dacomitinib hydrate
DACOMITINIB MONHYDRAT
Dacotinib monohydrate
Dacomitinib Monhydrate
PF-00299804 dacomitinib
Dacomitinib hydrate (PF-00299804
Dacomitinib (PF-00299804) Hydrate
(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide,hydrate
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide hydrate
(2E)-N-(4-(3-Chloro-4-fluorophenyl)amino)7-methoxyquinazolin-6-yl)4-(piperidin-1-yl)but-2-enamide monohydrate
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide hydrate (1:1) | [Molecular Formula]
C24H27ClFN5O3 | [MDL Number]
MFCD19443734 | [MOL File]
1042385-75-0.mol | [Molecular Weight]
487.954 |
| Hazard Information | Back Directory | [Uses]
PF299804 is a potent, irreversible pan-ErbB inhibitor against ErbB1, ErbB2 and ErbB4 with IC50 of 6 nM, 45.7 nM and 73.7 nM, respectively. |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.approvedhomemanagement.com/ShowSupplierProductsList15748/0.htm |
|